Sox9 suppresses the hypertrophy of chondrocytes by inhibiting wnt/β-catenin signaling pathway
Main Authors: | Kun Chen, Peng Cheng, Min Zhou, Yuting Wang, Anmin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Journal of Orthopaedic Translation |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214031X16302108 |
Similar Items
-
SDF-1α/CXCR4 promotes the hypertrophy of MSCs and articular chondrocytes by activating the Wnt/β-catenin signaling pathway
by: Yonghui Dong, et al.
Published: (2016-10-01) -
Role of Canonical Wnt/β-Catenin Pathway in Regulating Chondrocytic Hypertrophy in Mesenchymal Stem Cell-Based Cartilage Tissue Engineering
by: Xueqi Wang, et al.
Published: (2022-01-01) -
Role of Sox9 in BPD and its effects on the Wnt/β-catenin pathway and AEC-II differentiation
by: Di Wu, et al.
Published: (2024-01-01) -
SOX9 Inhibits the Progression of Osteonecrosis of the Femoral Head via the Activation of the Wnt/Beta-Catenin Pathway
by: Xiangsheng Meng, et al.
Published: (2023-12-01) -
KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
by: Hanhui Yao, et al.
Published: (2022-09-01)